Cloning and paratope analysis of an antibody fragment, a rational approach for the design of a PAI-1 inhibitor.

about

Cloning and paratope analysis of an antibody fragment, a rational approach for the design of a PAI-1 inhibitor.

Item

http://www.wikidata.org/entity/Q44783383

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Cloning and paratope analysis ...... e design of a PAI-1 inhibitor.

@en

Cloning and paratope analysis ...... e design of a PAI-1 inhibitor.

@nl

type

Item

label

Cloning and paratope analysis ...... e design of a PAI-1 inhibitor.

@en

Cloning and paratope analysis ...... e design of a PAI-1 inhibitor.

@nl

prefLabel

Cloning and paratope analysis ...... e design of a PAI-1 inhibitor.

@en

Cloning and paratope analysis ...... e design of a PAI-1 inhibitor.

@nl

P1476

Cloning and paratope analysis ...... e design of a PAI-1 inhibitor.

@en

P2093

Gils A

http://www.w3.org/2001/XMLSchema#string

Verbeke K

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody modeling: implications for engineering and design.

Plasminogen-activator inhibitor type 1 and coronary artery disease.

Improved cloning of antibody variable regions from hybridomas by an antisense-directed RNase H digestion of the P3-X63-Ag8.653 derived pseudogene mRNA.

Mimicking dominant negative inhibition of prion replication through structure-based drug design.

Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1.

Interconversions between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitor.

Modulation of plasminogen activator inhibitor type-1 biosynthesis in vitro and in vivo with oligo(nucleoside phosphorothioate)s and related constructs.

The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator.

A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands. Ligand-induced serpin polymerization.

The influence of the buried glutamine or glutamate residue in position 6 on the structure of immunoglobulin variable domains.

P304

289-297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1538-7933.2004.00582.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul Declerck

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6920766

http://www.w3.org/2001/XMLSchema#string

P698

14995992

http://www.w3.org/2001/XMLSchema#string